{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T13:03:44Z","timestamp":1772111024961,"version":"3.50.1"},"reference-count":38,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2003,2,3]],"date-time":"2003-02-03T00:00:00Z","timestamp":1044230400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2003,2,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>Loss of E\u2010cadherin expression is associated with aberrant 5\u2032 CpG island methylation in various tumors.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>The authors analyzed the methylation status and immunohistochemical expression of E\u2010cadherin in 142 endometrial tissues, consisting of 21 normal endometria, 17 endometrial hyperplasias, and 104 endometrial carcinomas.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>All normal endometria and endometrial hyperplasias showed positive staining of E\u2010cadherin, and methylation of the E\u2010cadherin gene was not detected in any samples. In endometrial carcinoma, the positive ratio of methylation was higher and was associated with tumor dedifferention and myometrial invasion. In G1 endometrial adenocarcinomas, 66.7% showed positive staining and 33.3% showed heterogeneous staining. Methylation of the E\u2010cadherin gene was detected in 15.6%. In G2 tumors, 19.0% showed positive staining, 69.0% showed heterogeneous staining and 11.9% showed negative staining. Methylation of the E\u2010cadherin gene was found in 50.0%. In G3 tumors, 9.1% showed positive staining, 54.5% showed heterogeneous staining and 36.3% showed negative staining. Methylation of the E\u2010cadherin gene was found in 81.8% of the tumors. Of the samples with no\u2010myometrial invasion, 23.1% had methylation. In those with invasion in less than half of the myometrium, 28.6% did and in those with invasion of half or more of the myometrium, 55.6% had methylation. Of samples that did not have lymph node metastasis, 33.7% had methylation, whereas of samples that had lymph node metastasis, 60.0% had methylation.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>This is the first report to analyze methylation of the E\u2010cadherin gene promoter of endometrial carcinoma and the evidence suggests that methylation of the E\u2010cadherin gene occurs in association with the acquisition of invasive capacity. Cancer 2003;97:1002\u20139. \u00a9 2003 American Cancer Society.<\/jats:p><jats:p>DOI 10.1002\/cncr.11157<\/jats:p><\/jats:sec>","DOI":"10.1002\/cncr.11157","type":"journal-article","created":{"date-parts":[[2003,2,5]],"date-time":"2003-02-05T20:48:46Z","timestamp":1044478126000},"page":"1002-1009","source":"Crossref","is-referenced-by-count":51,"title":["Hypermethylation in promoter region of E\u2010cadherin gene is associated with tumor dedifferention and myometrial invasion in endometrial carcinoma"],"prefix":"10.1002","volume":"97","author":[{"given":"Tsuyoshi","family":"Saito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,2,3]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2006419"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.108.6.2435"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90143-M"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.113.1.173"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1994.1113"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3835(91)90206-W"},{"key":"e_1_2_6_8_2","first-page":"2185","article-title":"Expression of E\u2010 and P\u2010cadherin in gastric carcinomas","volume":"51","author":"Shimoyama Y","year":"1991","journal-title":"Cancer Res."},{"key":"e_1_2_6_9_2","first-page":"6328","article-title":"E\u2010cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis","volume":"51","author":"Schipper JH","year":"1991","journal-title":"Cancer Res."},{"key":"e_1_2_6_10_2","first-page":"17","article-title":"Expression of immunoreactive E\u2010cadherin adhesion molecules in human cancers","volume":"139","author":"Shiozaki H","year":"1991","journal-title":"Am J Pathol."},{"key":"e_1_2_6_11_2","first-page":"987","article-title":"Correlation of E\u2010cadherin expression with differentiation grade and histological type in breast carcinoma","volume":"142","author":"Gamallo C","year":"1993","journal-title":"Am J Pathol."},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/366362a0"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0074-7696(08)62230-5"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-230X(08)60702-2"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/5947"},{"key":"e_1_2_6_16_2","first-page":"5195","article-title":"E\u2010cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas","volume":"55","author":"Graff JR","year":"1995","journal-title":"Cancer Res."},{"key":"e_1_2_6_17_2","first-page":"594","article-title":"Frequent down\u2010regulation of E\u2010cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas","volume":"7","author":"Matsumura T","year":"2001","journal-title":"Clin Cancer Res."},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65575-7"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1999.5662"},{"key":"e_1_2_6_20_2","first-page":"3262","article-title":"Cytosine\u2010phosphoguanine methylation of estrogen receptors in endometrial cancer","volume":"61","author":"Sasaki M","year":"2001","journal-title":"Cancer Res."},{"key":"e_1_2_6_21_2","first-page":"97","article-title":"Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer","volume":"61","author":"Sasaki M","year":"2001","journal-title":"Cancer Res."},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202092"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.18.9821"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.16.7416"},{"key":"e_1_2_6_25_2","first-page":"2463","article-title":"DNA methylation errors and cancer","volume":"56","author":"Jones PA","year":"1996","journal-title":"Cancer Res."},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10211"},{"key":"e_1_2_6_27_2","first-page":"464","article-title":"Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients","volume":"8","author":"Chan MW","year":"2002","journal-title":"Clin Cancer Res."},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20011201)92:11<2786::AID-CNCR10128>3.0.CO;2-I"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.1386"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)66047-8"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.7.569"},{"key":"e_1_2_6_32_2","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/ajcp\/77.5.534","article-title":"Carcinoma of the endometrium. II. Papillary adenocarcinoma: a clinical pathological study, 46 cases","volume":"77","author":"Christopherson WM","year":"1982","journal-title":"Am J Clin Pathol."},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004347-199001000-00001"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.240590921"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/383627a0"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-419X(94)90003-5"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2744(199907)25:3<207::AID-MC7>3.0.CO;2-4"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s007950200001"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004347-200207000-00007"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.11157","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:56:05Z","timestamp":1760302565000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.11157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2,3]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,2,15]]}},"alternative-id":["10.1002\/cncr.11157"],"URL":"https:\/\/doi.org\/10.1002\/cncr.11157","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2,3]]}}}